NCT03354611 2023-03-16
Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging
Koning Corporation
Phase 2/3 Terminated
Clinical Trials
10 trialsNCT00247975 2022-08-16
Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy
Ottawa Heart Institute Research Corporation
Phase 2/3 Terminated
NCT00448266 2021-01-22
Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD
The Netherlands Cancer Institute
Phase 2/3 Terminated
NCT03716050 2020-05-21
The Effect of Nitroglycerin Ointment, Fluorescent Angiography, and Incisional Negative Pressure Wound Therapy on Mastectomy Skin Flap Perfusion-Related Problems
Wake Forest University Health Sciences
Phase 2/3 Terminated
NCT01902823 2019-12-13
Effect of Cancer Nurse Navigators on Patient Outcomes
University of Wisconsin, Madison
Phase 2/3 Terminated
NCT00684216 2017-09-14
Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer
The Netherlands Cancer Institute
Phase 2/3 Terminated
NCT02213744 2017-01-06
HERMIONE
Merrimack Pharmaceuticals
Phase 2/3 Terminated
NCT01708798 2017-01-05
Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer
University of British Columbia
Phase 2/3 Terminated
NCT01355523 2014-05-06
MELODY
Herlev Hospital
Phase 2/3 Terminated
NCT00049660 2012-07-18
Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2/3 Terminated